During our 100+ years as a full-service, growth investment bank, we‘ve empowered our clients’ success by delivering a depth and breadth of insights across a broad range of sectors and capabilities.
Ahead of the Curve®
Jul 7, 2023
Is Synthetic Biology Reaching A Tipping Point?
Read More >
Ahead of the Curve®
Dec 28, 2022
Single Cell & Spatialomics: What Does The Future Hold?
Read More >
Ahead of the Curve®
Nov 3, 2022
Profoundly Expanding the Target Space: A Primer on TPD
Read More >
Video
Oct 6, 2022
Cowen Interviews: What is a moment in your company’s development that captured your passion for the life sciences?
Read More >
Ahead of the Curve®
Oct 3, 2022
The PRMT5 Edge: Every Uncertainty Presents an Opportunity
Read More >
Ahead of the Curve®
Jun 9, 2022
Forward Progress: ESG Primer on Clinical Trial Diversity
Read More >
Ahead of the Curve®
May 31, 2022
Growing Up Ras: Resistance, Combos & Next Gen Agents
Read More >
Apr 29, 2022
Investment Banking First Quarter 2022
Read More >
Ahead of the Curve®
Mar 11, 2022
Synthetic Biology 2.0: High-Growth Vertical Disrupting Many End Markets
Read More >
Feb 16, 2022
2021 Investment Banking Year in Review
Read More >
Ahead of the Curve®
Nov 16, 2021
Trials and Triumphs of Gene Editing: A Compendium
Read More >
Ahead of the Curve®
Oct 15, 2021
Fueling the Future: A Primer on Cell and Gene Therapy Tools
Read More >
In order to optimize our website for you and to be able to continuously improve it, we use cookies. By continuing to use the website, you agree to the use of cookies. Further information on cookies can be found in our Privacy Policy.
